aspirin has been researched along with Brain Thrombosis in 39 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antithrombotic, antiplatelet and endothelial activity of terutroban, a specific thromboxane prostaglandin receptor antagonist, was assessed in patients previously treated with aspirin for the prevention of ischemic stroke." | 9.14 | Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke. ( Bal Dit Sollier, C; Bergmann, JF; Bousser, MG; Crassard, I; Drouet, L; Simoneau, G, 2009) |
| "Warfarin, in combination with aspirin or given alone, was superior to aspirin alone in reducing the incidence of composite events after an acute myocardial infarction but was associated with a higher risk of bleeding." | 9.10 | Warfarin, aspirin, or both after myocardial infarction. ( Abdelnoor, M; Arnesen, H; Erikssen, J; Hurlen, M; Smith, P, 2002) |
| "Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature." | 5.33 | Arterial thrombosis in four patients treated with thalidomide. ( Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K, 2005) |
| "The antithrombotic, antiplatelet and endothelial activity of terutroban, a specific thromboxane prostaglandin receptor antagonist, was assessed in patients previously treated with aspirin for the prevention of ischemic stroke." | 5.14 | Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke. ( Bal Dit Sollier, C; Bergmann, JF; Bousser, MG; Crassard, I; Drouet, L; Simoneau, G, 2009) |
| "Warfarin, in combination with aspirin or given alone, was superior to aspirin alone in reducing the incidence of composite events after an acute myocardial infarction but was associated with a higher risk of bleeding." | 5.10 | Warfarin, aspirin, or both after myocardial infarction. ( Abdelnoor, M; Arnesen, H; Erikssen, J; Hurlen, M; Smith, P, 2002) |
| " In the CAPRIE (Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events) Trial, clopidogrel (clopidogrel bisulphate) was superior to acetylsalicylic acid (ASA) in reducing the combined risk of ischaemic stroke (IS), myocardial infarction (MI) or vascular death in patients with symptomatic atherosclerosis." | 4.81 | From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients. ( Hacke, W, 2002) |
| " Prevention with aspirin or heparin was administered in ten cases during pregnancy, and in all the cases with heparin in postpartum." | 3.81 | [Thrombosis risk during pregnancy after history of cerebral venous thrombosis]. ( Neau, JP; Pierre, F; Pouget-Abadie, JF; Pourrat, O, 2015) |
| " The patient was subsequently found to have incomplete inhibition of platelet activity despite being on clopidogrel 150 mg and aspirin 81 mg daily and having a normal CYP-2C19 genotype, suggesting that suboptimal antiplatelet inhibition, secondary to morbid obesity, contributed to his in-stent thrombosis." | 3.79 | Obesity and intracranial in-stent thrombosis. ( Koch, S; Reyes-Iglesias, Y; Rose, DZ; Yavagal, DR, 2013) |
| " We report an independent 88-year-old female, on aspirin only for chronic atrial fibrillation, who presented with a 12-hour history of acute lumbar back pain, urinary incontinence and progressive bilateral lower limb paresis." | 3.76 | Spontaneous spinal epidural haematoma in a geriatric patient on aspirin. ( Dimou, J; Jithoo, R; Morokoff, A, 2010) |
| "Warfarin increases both the likelihood and the mortality of intracerebral hemorrhage (ICH), particularly in patients with a history of prior ICH." | 3.72 | Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. ( Eckman, MH; Greenberg, SM; Knudsen, KA; Rosand, J; Singer, DE, 2003) |
| "Hemorrhagic stroke is the most common type of obstetric stroke." | 2.72 | Stroke in Pregnancy: A Multidisciplinary Approach. ( Camargo, EC; Singhal, AB, 2021) |
| "Aspirin is a more potent inhibitor of Cox-1 than of Cox-2, unlike other non-steroidal anti-inflammatory drugs (NSAIDs), which have limited selectivity." | 2.41 | Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects. ( Catella-Lawson, F, 2001) |
| "Imaging revealed an acute cerebral venous thrombosis." | 1.48 | CO poisoning as an associated risk factor for CVT. ( Gibb, GJ; Laghari, FJ; Phinney, TA, 2018) |
| "Aspirin was restarted on the first postoperative day and clopidogrel was restarted on the second postoperative day." | 1.38 | Perioperative management of a neurosurgical patient requiring antiplatelet therapy. ( Gregory Thompson, B; Rohatgi, P; Than, KD; Wilson, TJ, 2012) |
| "Aspirin resistance was determined by platelet aggregation (>20%) to one or more of the four agonists, namely arachidonic acid (1." | 1.35 | Aspirin resistance in South African Caucasian patients with thrombotic cerebrovascular events. ( Becker, PJ; Bernstein, PL; Connor, MD; Jacobson, BF, 2009) |
| "Thalidomide has been associated with venous thrombotic events, as reported in the post-marketing surveillance reports by Celgene Corporation; as well as case reports in the literature." | 1.33 | Arterial thrombosis in four patients treated with thalidomide. ( Brown, K; Chanan-Khan, A; Hahn, T; McCarthy, PL; Paplham, P; Roy, H; Scarpace, SL; van Besien, K, 2005) |
| "Strokes were subtyped according to inferred mechanism." | 1.32 | Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study. ( Barzegar, S; Bauer, K; Costigan, T; Furie, KL; Kistler, JP; Mohr, JP; Rosenberg, R; Rosner, B; Sciacca, R; Thompson, JL; Thornell, B, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.56) | 18.2507 |
| 2000's | 18 (46.15) | 29.6817 |
| 2010's | 18 (46.15) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, BE | 1 |
| Bhatt, DL | 1 |
| Camargo, EC | 1 |
| Singhal, AB | 1 |
| Phinney, TA | 1 |
| Gibb, GJ | 1 |
| Laghari, FJ | 1 |
| Godier, A | 1 |
| Mesnil, M | 1 |
| De Mesmay, M | 1 |
| Dagois, S | 1 |
| Thion, LA | 1 |
| Dupont, C | 1 |
| Mazighi, M | 1 |
| Devys, JM | 1 |
| Pourrat, O | 1 |
| Neau, JP | 1 |
| Pouget-Abadie, JF | 1 |
| Pierre, F | 1 |
| Pumar, JM | 1 |
| Banguero, A | 1 |
| Arias-Rivas, S | 1 |
| Blanco, M | 2 |
| Rodríguez-Yáñez, M | 1 |
| Sucasas, P | 1 |
| Castiñeira-Mourenza, JA | 1 |
| Vázquez-Herrero, F | 1 |
| Joly, B | 1 |
| Menard, AL | 1 |
| Ozkul-Wermester, O | 1 |
| Triquenot-Bagan, A | 1 |
| Guegan-Massardier, E | 1 |
| Borg, JY | 1 |
| Le Cam-Duchez, V | 1 |
| Mahawish, K | 1 |
| Barinov, EF | 1 |
| Mamedaliyeva, S | 1 |
| Tverdokhleb, TA | 1 |
| Martinez-Moreno, R | 1 |
| Aguilar, M | 1 |
| Wendl, C | 1 |
| Bäzner, H | 1 |
| Ganslandt, O | 1 |
| Henkes, H | 1 |
| Hagen, MW | 1 |
| Girdhar, G | 1 |
| Wainwright, J | 1 |
| Hinds, MT | 1 |
| Connors, CW | 1 |
| Nguyen, JD | 1 |
| Bernstein, PL | 1 |
| Jacobson, BF | 1 |
| Connor, MD | 1 |
| Becker, PJ | 1 |
| Bal Dit Sollier, C | 1 |
| Crassard, I | 1 |
| Simoneau, G | 1 |
| Bergmann, JF | 1 |
| Bousser, MG | 1 |
| Drouet, L | 1 |
| Gomez, CR | 1 |
| Qureshi, AI | 1 |
| Dimou, J | 1 |
| Jithoo, R | 1 |
| Morokoff, A | 1 |
| Rechner, AR | 1 |
| Meckel, S | 1 |
| Singh, TP | 1 |
| Undrén, P | 1 |
| Ramgren, B | 1 |
| Nilsson, OG | 1 |
| Phatouros, C | 1 |
| McAuliffe, W | 1 |
| Cronqvist, M | 1 |
| Suslina, ZA | 1 |
| Tanashian, MM | 1 |
| Domashenko, MA | 1 |
| Lansberg, MG | 1 |
| O'Donnell, MJ | 1 |
| Khatri, P | 1 |
| Lang, ES | 1 |
| Nguyen-Huynh, MN | 1 |
| Schwartz, NE | 1 |
| Sonnenberg, FA | 1 |
| Schulman, S | 1 |
| Vandvik, PO | 1 |
| Spencer, FA | 1 |
| Alonso-Coello, P | 1 |
| Guyatt, GH | 1 |
| Akl, EA | 1 |
| Asil, T | 1 |
| Ir, N | 1 |
| Karaduman, F | 1 |
| Cagli, B | 1 |
| Tuncel, S | 1 |
| Than, KD | 1 |
| Rohatgi, P | 1 |
| Wilson, TJ | 1 |
| Gregory Thompson, B | 1 |
| Rose, DZ | 1 |
| Koch, S | 1 |
| Reyes-Iglesias, Y | 1 |
| Yavagal, DR | 1 |
| Hurlen, M | 1 |
| Abdelnoor, M | 1 |
| Smith, P | 1 |
| Erikssen, J | 1 |
| Arnesen, H | 1 |
| Eckman, MH | 1 |
| Rosand, J | 1 |
| Knudsen, KA | 1 |
| Singer, DE | 1 |
| Greenberg, SM | 1 |
| Crome, P | 1 |
| Epstein, EF | 1 |
| Furie, KL | 1 |
| Rosenberg, R | 1 |
| Thompson, JL | 1 |
| Bauer, K | 1 |
| Mohr, JP | 1 |
| Rosner, B | 1 |
| Sciacca, R | 1 |
| Barzegar, S | 1 |
| Thornell, B | 1 |
| Costigan, T | 1 |
| Kistler, JP | 1 |
| Scarpace, SL | 1 |
| Hahn, T | 1 |
| Roy, H | 1 |
| Brown, K | 1 |
| Paplham, P | 1 |
| Chanan-Khan, A | 1 |
| van Besien, K | 1 |
| McCarthy, PL | 1 |
| Hori, M | 1 |
| Fiorella, D | 1 |
| Thiabolt, L | 1 |
| Albuquerque, FC | 1 |
| Deshmukh, VR | 1 |
| McDougall, CG | 1 |
| Rasmussen, PA | 1 |
| Katkova, OV | 1 |
| Laguta, PS | 1 |
| Panchenko, EP | 1 |
| Lee, DH | 1 |
| Arat, A | 1 |
| Morsi, H | 1 |
| Shaltoni, H | 1 |
| Harris, JR | 1 |
| Mawad, ME | 1 |
| Kawano, KI | 1 |
| Fujishima, K | 1 |
| Ikeda, Y | 1 |
| Kondo, K | 1 |
| Umemura, K | 1 |
| Lenzi, GL | 1 |
| Lenzi, J | 1 |
| Mostardini, C | 1 |
| Wada, Y | 1 |
| Mizushige, K | 1 |
| Ohmori, K | 1 |
| Iwado, Y | 1 |
| Kohno, M | 1 |
| Matsuo, H | 1 |
| Catella-Lawson, F | 1 |
| Müller, TH | 1 |
| Morais, J | 1 |
| Hacke, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.[NCT00222261] | Phase 4 | 1,001 participants (Actual) | Interventional | 2003-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for aspirin and Brain Thrombosis
| Article | Year |
|---|---|
Looking into the next decade of antithrombotic therapy for patients with atrial fibrillation and percutaneous coronary intervention.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiology; Coronary Thrombosis; Drug Therapy, Combina | 2020 |
Stroke in Pregnancy: A Multidisciplinary Approach.
Topics: Aspirin; Brain Diseases; Cardiomyopathies; Cesarean Section; Eclampsia; Embolism, Paradoxical; Femal | 2021 |
Platelet function testing in clinical diagnostics.
Topics: Aspirin; Clopidogrel; Coronary Thrombosis; Hemorrhage; Humans; Intracranial Embolism; Intracranial T | 2011 |
[Resistance to antiplatelet drugs in patients with cerebrovascular disorders].
Topics: Arachidonate Lipoxygenases; Aspirin; Biotransformation; Blood Platelets; Clopidogrel; Dose-Response | 2011 |
Antiplatelet therapy in neuroendovascular therapeutics.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Intracranial Aneurysm | 2005 |
[Therapy with aspirin: a new look at the old problem].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biological Availability; Coronary Thrombosis; Cycl | 2007 |
Vascular biology of thrombosis: platelet-vessel wall interactions and aspirin effects.
Topics: Aspirin; Blood Platelets; Cell Communication; Cerebral Arteries; Humans; Intracranial Thrombosis; Pl | 2001 |
Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
Topics: Aspirin; Blood Platelets; Cell Communication; Cerebral Arteries; Clinical Trials, Phase I as Topic; | 2001 |
From CURE to MATCH: ADP receptor antagonists as the treatment of choice for high-risk atherothrombotic patients.
Topics: Angina, Unstable; Aspirin; Clopidogrel; Drug Therapy, Combination; Heparin; Humans; Intracranial Art | 2002 |
4 trials available for aspirin and Brain Thrombosis
| Article | Year |
|---|---|
Effect of the thromboxane prostaglandin receptor antagonist terutroban on arterial thrombogenesis after repeated administration in patients treated for the prevention of ischemic stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug | 2009 |
Warfarin, aspirin, or both after myocardial infarction.
Topics: Aged; Anticoagulants; Aspirin; Disease-Free Survival; Drug Therapy, Combination; Female; Hemorrhage; | 2002 |
Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction.
Topics: Aspirin; Blood Platelets; Cell Communication; Cerebral Arteries; Clinical Trials, Phase I as Topic; | 2001 |
Insights from CURE: using clopidogrel on top of standard therapy.
Topics: Aged; Angina, Unstable; Aspirin; Clopidogrel; Double-Blind Method; Female; Follow-Up Studies; Hepari | 2002 |
27 other studies available for aspirin and Brain Thrombosis
| Article | Year |
|---|---|
CO poisoning as an associated risk factor for CVT.
Topics: Anticoagulants; Aspirin; Carbon Monoxide Poisoning; Female; Headache Disorders; Humans; Intracranial | 2018 |
Bridging antiplatelet therapy with cangrelor in patients with recent intracranial stenting undergoing invasive procedures: a prospective case series.
Topics: Adenosine Monophosphate; Aspirin; Brain; Female; Fibrinolytic Agents; Humans; Intracranial Aneurysm; | 2019 |
[Thrombosis risk during pregnancy after history of cerebral venous thrombosis].
Topics: Adult; Anticoagulants; Aspirin; Chemoprevention; Family Health; Female; Humans; Intracranial Thrombo | 2015 |
[Rescue treatment in acute thrombosis of intracranial stents].
Topics: Abciximab; Antibodies, Monoclonal; Aspirin; Basilar Artery; Capillary Permeability; Cerebral Angiogr | 2014 |
Involvement of Arg306 mutation in factor V gene in two young men with ischemic stroke.
Topics: Anticholesteremic Agents; Arginine; Aspirin; Brain Ischemia; DNA Mutational Analysis; Factor V; Fibr | 2014 |
Hyperdense basilar artery sign.
Topics: Aspirin; Basilar Artery; Diagnosis, Differential; Fibrinolytic Agents; Heparin; Humans; Intracranial | 2015 |
[Interaction of the Humoral Agonist During the Platelets Activation in Patients with Chronic Cerebral Ischemia].
Topics: Adenosine Diphosphate; Adult; Aspirin; Blood Platelets; Brain; Brain Ischemia; Chronic Disease; Epin | 2015 |
Fatal Thrombosis of a Flow Diverter due to Ibuprofen-related Antagonization of Acetylsalicylic Acid.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Vessel Prosthesis; Drug Antagonism; Drug Int | 2016 |
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification.
Topics: Animals; Arteriovenous Shunt, Surgical; Aspirin; Clopidogrel; Embolization, Therapeutic; Intracrania | 2017 |
Management of a Patient Requiring Intrathecal Drain Insertion and Removal in the Setting of Concomitant Dual Antiplatelet Therapy With Clopidogrel and Aspirin: A Case Report.
Topics: Aspirin; Catheters, Indwelling; Clopidogrel; Device Removal; Drainage; Drug Therapy, Combination; En | 2017 |
Aspirin resistance in South African Caucasian patients with thrombotic cerebrovascular events.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Drug Resistance; Female; Humans; Intracranial Thrombosis; M | 2009 |
Medical treatment of patients with intracranial atherosclerotic disease.
Topics: Anticoagulants; Aspirin; Atherosclerosis; Brain Ischemia; Cilostazol; Clopidogrel; Dipyridamole; Emb | 2009 |
Spontaneous spinal epidural haematoma in a geriatric patient on aspirin.
Topics: Age Factors; Aged, 80 and over; Aspirin; Atrial Fibrillation; Decompression, Surgical; Female; Hemat | 2010 |
Endovascular treatment using predominantly stent-assisted coil embolization and antiplatelet and anticoagulation management of ruptured blood blister-like aneurysms.
Topics: Adult; Aged; Aneurysm, Ruptured; Anticoagulants; Aspirin; Cerebral Angiography; Clopidogrel; Combine | 2011 |
Antithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Topics: Aspirin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Evi | 2012 |
Combined antithrombotic treatment with aspirin and clopidogrel for patients with capsular warning syndrome: a case report.
Topics: Aged; Aspirin; Clopidogrel; Female; Humans; Internal Capsule; Intracranial Thrombosis; Ischemic Atta | 2012 |
Perioperative management of a neurosurgical patient requiring antiplatelet therapy.
Topics: Aged; Aspirin; Cerebral Angiography; Clopidogrel; Humans; Intracranial Aneurysm; Intracranial Thromb | 2012 |
Obesity and intracranial in-stent thrombosis.
Topics: Abciximab; Angioplasty, Balloon; Antibodies, Monoclonal; Aspirin; Body Mass Index; Brain Ischemia; C | 2013 |
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Cohort Studies; Decision Su | 2003 |
Using prescribing indicators to measure the quality of prescribing to elderly medical in-patients.
Topics: Aged; Aspirin; Drug Prescriptions; Humans; Intracranial Thrombosis; Medical Records; Warfarin | 2004 |
Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biomarkers; Brain Infarction; Brain Ischemia; Coho | 2004 |
Arterial thrombosis in four patients treated with thalidomide.
Topics: Aged; Arterial Occlusive Diseases; Aspirin; Drug Therapy, Combination; Female; Humans; Intracranial | 2005 |
[Primary prevention of thrombosis for patients with atrial fibrillation].
Topics: Aged; Aspirin; Atrial Fibrillation; Humans; Intracranial Thrombosis; Japan; Practice Guidelines as T | 2004 |
Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience.
Topics: Adult; Aged; Angioplasty, Balloon; Aspirin; Cerebrovascular Disorders; Clopidogrel; Drug Administrat | 2008 |
ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Topics: Amides; Animals; Arterial Occlusive Diseases; Aspirin; Bleeding Time; Cerebrovascular Circulation; F | 2000 |
Thromboembolic neurologic events in patients with antiphospholipid-antibody syndrome.
Topics: Administration, Oral; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Autoimmune Diseases; Hemor | 1999 |
Prevention of cerebral thromboembolism by low-dose anticoagulant therapy in atrial fibrillation with mitral regurgitation.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebrovascular Circulation; Echocardiography; F | 2001 |